Trademark: 79139817
Word
MAGLUMI
Status
Registered
Status Code
706
Status Date
Monday, May 2, 2022
Serial Number
79139817
Registration Number
4683169
Registration Date
Tuesday, February 10, 2015
Mark Type
5000
Filing Date
Wednesday, July 17, 2013
Published for Opposition
Tuesday, November 25, 2014

Trademark Owner History

Classifications
5 Drugs for medical purposes for treatment of tumors, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, TORCH infections and immunoglobulin disease; medicated serums for invitro diagnosis and treatment; medicated serums for in-vivo diagnosis and treatment; serotherapeutic medicines; cultures of microorganisms for medical and veterinary use; biological preparations for pharmaceutical purposes for treatment of tumors, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, TORCH infections and immunoglobulin diseases; chemical preparations for pharmaceutical purposes, namely, for diagnosis or treatment of tumors, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, TORCH infections and immunoglobulin diseases; Diagnostic preparations for medical purposes, namely, for diagnosing or detecting tumors, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, TORCH infections and immunoglobulin diseases; enzymes for medical purposes; enzyme preparations for medical purposes; chemical preparations for the diagnosis of pregnancy
10 Blood testing apparatus; [ massage apparatus; ] apparatus for use in medical analysis, namely, medical analyzer for analysis of blood samples, body fluids and body tissue samples; testing apparatus for medical purposes, namely, medical testing instrument for testing blood samples, body fluids and body tissue samples; diagnostic apparatus for medical purposes, namely, medical diagnostic analyzer for analyzing blood samples, body fluids and body tissue samples; radiotherapy apparatus; ultrasonic devices and parts thereof for medical use, namely, clinical ultrasonic diagnostic apparatus and parts thereof [ ; artificial limbs; multifunction corsets for medical purpose, namely, diagnosis and therapeutic corsets for medical purpose; suture materials ]
The mark consists of the stylized words "MAGLUMI".
Color is not claimed as a feature of the mark.
The wording "MAGLUMI" has no meaning in a foreign language.

Trademark Events
Feb 10, 2024
Courtesy Reminder - Sec. 71 (10-Yr) E-Mailed
May 12, 2023
International Registration Renewed
Apr 12, 2023
Partial Invalidation Processed By The Ib
Feb 22, 2023
Generic Madrid Transaction Sent To Ib
Feb 22, 2023
Generic Madrid Transaction Created
Jan 2, 2023
Partial Invalidation Of Reg Ext Protection Created
May 2, 2022
Notice Of Acceptance Of Sec. 71 - E-Mailed
May 2, 2022
Registered-Sec.71 Accepted
Nov 19, 2021
Teas Response To Office Action-Post Reg Received
Oct 27, 2021
Post Registration Action Mailed - Sec.71
Oct 25, 2021
Post Registration Action Mailed - Sec.71
Oct 25, 2021
Reinstated
Oct 16, 2021
Notice Of Cancellation Sec. 71 E-Mailed
Oct 15, 2021
Cancelled Section 71
Mar 11, 2021
Post Registration Action Mailed - Sec.71
Mar 4, 2021
Case Assigned To Post Registration Paralegal
Feb 7, 2021
Teas Section 71 Received
Feb 20, 2020
Change Of Name/Address Rec'd From Ib
Nov 26, 2015
Change Of Name/Address Rec'd From Ib
Jun 27, 2015
Final Decision Transaction Processed By Ib
Jun 11, 2015
Final Disposition Notice Sent To Ib
Jun 11, 2015
Final Disposition Processed
May 10, 2015
Final Disposition Notice Created, To Be Sent To Ib
Feb 10, 2015
Registered-Principal Register
Jan 13, 2015
Correction From The Ib Examined, No Action Is Needed
Jan 3, 2015
Correction Transaction Received From Ib
Nov 25, 2014
Published For Opposition
Nov 5, 2014
Notice Of Publication
Oct 23, 2014
Law Office Publication Review Completed
Oct 22, 2014
Examiners Amendment Mailed
Oct 22, 2014
Approved For Pub - Principal Register
Oct 22, 2014
Examiner's Amendment Entered
Oct 22, 2014
Examiners Amendment -Written
Oct 14, 2014
Teas/Email Correspondence Entered
Oct 13, 2014
Correspondence Received In Law Office
Oct 13, 2014
Teas Request For Reconsideration Received
May 27, 2014
Final Refusal Mailed
May 26, 2014
Final Refusal Written
Apr 17, 2014
Teas/Email Correspondence Entered
Apr 17, 2014
Correspondence Received In Law Office
Apr 8, 2014
Assigned To Lie
Mar 28, 2014
Assigned To Lie
Mar 17, 2014
Teas Response To Office Action Received
Jan 17, 2014
Refusal Processed By Ib
Dec 30, 2013
Non-Final Action Mailed - Refusal Sent To Ib
Dec 30, 2013
Refusal Processed By Mpu
Dec 21, 2013
Non-Final Action (Ib Refusal) Prepared For Review
Dec 20, 2013
Non-Final Action Written
Dec 18, 2013
Application Filing Receipt Mailed
Dec 14, 2013
Assigned To Examiner
Dec 14, 2013
New Application Office Supplied Data Entered
Dec 12, 2013
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24